Clinical trial
A Study Evaluating the Effect of Etoricoxib and Indomethacin in the Treatment of…
NCT00142558 · Organon and Co, Industry · Completed
Key facts
| NCT number | NCT00142558 |
|---|---|
| Title | A Study Evaluating the Effect of Etoricoxib and Indomethacin in the Treatment of Acute Gout (0663-081)(COMPLETED) |
| Official title | A Randomized, Double-Blind, Active-Comparator-Controlled 5-Day Trial of the Effect of Etoricoxib 120 mg Versus Indomethacin 150 mg in the Treatment of Acute Gout |
| Lead sponsor | Organon and Co, Industry |
| Status | Completed |
| Phase | Phase 4 |
| Study type | Interventional |
| Conditions | Acute Gout |
| Intervention type | Drug |
| Interventions | MK0663, etoricoxib / Duration of Treatment: 5 Days, Comparator: indomethacin 75 mg sustained release capsule / Duration of Treatment: 5 Days |
| Enrollment | 180 |
| Start date | Jan 1, 2005 |
| Primary completion | May 1, 2005 |
| Completion | May 1, 2005 |
| First posted | Sep 2, 2005 |
| Last update posted | Aug 15, 2024 |
At a glance
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: